4DTK
Novel and selective pan-PIM kinase inhibitor
Summary for 4DTK
Entry DOI | 10.2210/pdb4dtk/pdb |
Descriptor | Serine/threonine-protein kinase pim-1, 1,2-ETHANEDIOL, (5Z)-5-{2-[(3R)-3-aminopiperidin-1-yl]-3-(propan-2-yloxy)benzylidene}-1,3-thiazolidine-2,4-dione, ... (5 entities in total) |
Functional Keywords | pim1, kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Isoform 2: Cytoplasm. Isoform 1: Cell membrane: P11309 |
Total number of polymer chains | 1 |
Total formula weight | 32893.26 |
Authors | Ferguson, A.D. (deposition date: 2012-02-21, release date: 2012-07-11, Last modification date: 2024-02-28) |
Primary citation | Dakin, L.A.,Block, M.H.,Chen, H.,Code, E.,Dowling, J.E.,Feng, X.,Ferguson, A.D.,Green, I.,Hird, A.W.,Howard, T.,Keeton, E.K.,Lamb, M.L.,Lyne, P.D.,Pollard, H.,Read, J.,Wu, A.J.,Zhang, T.,Zheng, X. Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases. Bioorg.Med.Chem.Lett., 22:4599-4604, 2012 Cited by PubMed Abstract: Novel substituted benzylidene-1,3-thiazolidine-2,4-diones (TZDs) have been identified as potent and highly selective inhibitors of the PIM kinases. The synthesis and SAR of these compounds are described, along with X-ray crystallographic, anti-proliferative, and selectivity data. PubMed: 22727640DOI: 10.1016/j.bmcl.2012.05.098 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.86 Å) |
Structure validation
Download full validation report